Official UK procurement notice
Supply of testing for SARS-CoV-2 antibody and PCR testing
Authority: NHS Blood and Transplant (Central government)
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Blood analysis services
The lotProcurement structure
single lot · no lot value publishedLot #1NHS Blood and Transplant (NHSBT) are leading the Convalescent Plasma programme to…
NHS Blood and Transplant (NHSBT) are leading the Convalescent Plasma programme to explore the efficacy of donated plasma in the treatment of severe COVID-19 disease. Plasma will be donated by individuals who have recovered from COVID-19 disease and those plasma units with a sufficiently high level of antibody will be used as a treatment. Public Health England (PHE) will be carrying out Testing on the Materials on behalf of NHSBT. This will involve a SARS-CoV-2 IgG antibody Testing service (using a CE-marked assay) to NHSBT to enable the identification of convalescent plasma donations with sufficient level of antibody.
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 16 Mar 2021, 22:56 GMT
- Last source update
- 16 Mar 2021, 22:56 GMT
- Authority reference
NHSBT1386- FTS notice number
2021/S 000-005366- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-029c67Find a Tender
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Public Health EnglandSupply of testing for SARS-CoV-2 antibody testing | £380,000 † | — | Awarded |
Contracts
Supply of testing for SARS-CoV-2 antibody testing · Public Health England
- Signed
- 16 Mar 2021
- Value
- £380,000
- Period
- … – 31 Mar 2022
- Status
- active
- Change Duration extended from 31st March 2021 to 31st March 2022 to allow for testing of c. 7000 research samples from the RECOVERY clinical trial., Need for additional works, services or supplies by the original contractor/concessionaire: The Rare and Imported Pathogens Laboratory (RIPL) based at PHE Porton (Sailsbury), providing the SARS-CoV-2 IgG antibody testing service, have experience in handling samples from NHSBT meeting all criteria specified in section 4.1 of the Project Schedule (dated 3rd March 2021). It is the only facility of its type within the UK that has the expertise to perform a quantitative test for SARS-CoV-2 IgG with a linear correlation with neutralising antibody over a very wide range of titres at the scale and speed required to meet the time pressures associated with the convalescent plasma programme.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- NHS Blood and TransplantReview body
Bidders & participating suppliers
1 commercial party on the notice- Public Health EnglandAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.